Qurdac 60 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Qurdac 60 mg Tablet contains daclatasvir, a hepatitis C virus NS5A inhibitor. Its labelling describes it for the treatment of chronic hepatitis C virus (HCV) infection, including genotypes 1, 2, 3, and 4, used in combination with other antiviral medicines. It is described as taken once daily at the same time each day, with or without food as directed by the prescriber.
Product Information
The following description reflects information associated with daclatasvir and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of chronic hepatitis C virus infection, including genotypes 1, 2, 3, and 4
- Described as used together with other antiviral medicines, not on its own
- Described as blocking the NS5A protein that the virus needs to multiply and spread
Described Dosage & Administration
- Taken by mouth once daily, at about the same time each day, with or without food as directed by the prescriber
- The prescriber sets the dose, combination, and duration after reviewing the patient’s health reports
- Tablets should be swallowed whole — not chewed or crushed
- Doses should not be missed, and the full course should be completed
Described Side Effects
Side effects are described as uncommon; where they occur they may include:
- Headache
- Nausea
- Weakness (fatigue)
These are described as generally not serious. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- The prescriber should be told about all other medicines being taken, as some are described as altering the effect of daclatasvir
- Complete medical history and current health reports should be shared before starting treatment
- Pregnant women and breastfeeding mothers should consult their doctor before starting the medicine
- Any persistent or severe side effect should be reviewed by a clinician
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains daclatasvir, an HCV NS5A inhibitor used with other antiviral medicines to treat chronic hepatitis C virus infection, including genotypes 1 to 4. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as taken by mouth once daily at about the same time each day, with or without food as directed, and swallowed whole. The prescriber sets the combination and duration; doses should not be missed.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.